Drug Type Fc fusion protein |
Synonyms HCB 303, HCB303 |
Target |
Action modulators |
Mechanism CD47 modulators(Cluster of differentiation 47 modulators), PDL1 modulators(Programmed death-ligand 1 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Non-Hodgkin Lymphoma | Preclinical | Taiwan Province | 01 Aug 2025 | |
Solid tumor | Preclinical | Taiwan Province | 01 Aug 2025 |